Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
Open Access
- 11 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 950831
Abstract
Discoidin, CUB, and LCCL domain-containing protein 2 (DCBLD2) is a two-domain transmembrane protein-coding gene located on chromosome 3, the protein expressed by which acts as the membrane receptor of semaphorin and vascular endothelial growth factor during the development of axons and blood vessels. Although several research evidences at the cellular and clinical levels have associated DCBLD2 with tumorigenesis, nothing is known regarding this gene from a pan-cancer standpoint. In this study, we systematically analyzed the influence of DCBLD2 on prognosis, cancer staging, immune characteristics, and drug sensitivity in a variety of cancers based on a unified and standardized pan-cancer dataset. In addition, we performed GO enrichment analyses and KEGG analyses of DCBLD2-related genes and DCBLD2-binding proteins. Our results showed that DCBLD2 is a potential oncogenic, immunological as well as a prognostic biomarker in terms of pan-cancer, and is expected to contribute to the improvement of tumor prognosis and the development of targeted therapy.Keywords
This publication has 52 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing TheoriesJournal of Cancer, 2013
- GPS-Prot: A web-based visualization platform for integrating host-pathogen interaction dataBMC Bioinformatics, 2011
- Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune diseaseClinical Immunology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Epigenetic Down-Regulation and Suppressive Role of DCBLD2 in Gastric Cancer Cell Proliferation and InvasionMolecular Cancer Research, 2008
- CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cellsOncogene, 2007
- Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivoOncogene, 2002